$20 billion in cardiovascular drug revenues soon subject to patent expiration More than $20 billion in main cardiovascular drug revenues can be exposed to patent expiration within the next three to five years, according to a written report by business intelligence firm LEADING EDGE Information. The record, entitled Cardiovascular Marketing: Budgets, Strategy and Staffing, available on the web, highlights the need of being in a position to adapt to the speedy and constant change seen in the pharmaceutical cardiovascular market. Pharmaceutical companies spend even more to aid a cardiovascular compound’s development and commercialization than they do on any various other therapeutic products.Children have meals or digestive allergies The number of young people who had a food or digestive allergy increased 18 % between 1997 and 2007, according to a new report by the Centers intended for Disease Prevention and Control. In 2007, approximately 3 million U.S. Children and teens under age 18 – – or almost 4 % of this age group – – were reported to have a food or digestive allergy in the last 12 months, compared to just over 2.3 million in 1997. The findings are published in a fresh data brief, Food Allergy Among U.S. Children: Tendencies in Prevalence and Hospitalizations. The info are from the National Health Interview Survey and the National Medical center Discharge Survey, both carried out by CDC's National Middle for Health Statistics.